I am a researcher participating in the NIH I-Corps program for a start-up biopharmaceutical company, POP Biotechnologies, seeking to validate the potential of a unique light-activated drug delivery system for the localized and enhanced treatment of discrete tumors. As an SBIR awardee, we are working to refine our clinical development plan through participation in the NIH I-Corps program.
POP Biotechnologies is exploring inflammatory breast cancer and cutaneous lesions associated with breast cancer as first-in-human clinical targets and seeking to identify other commercially viable targets compatible with their approach.
In support of our research, I am looking to interview people involved in the treatment of inflammatory breast cancer or cutaneous metastatic breast cancer. I am looking to conduct 10-15 minute interviews regarding treatment processes, support services, or other activities involved in planning / implementing treatment.
If you, or someone you know, would be interested in participating in an interview, please send me a PM — it would be really helpful.
I will happily send a nonconfidential summary of our technology to anyone interested, you can read more about our approach at http://popbiotech.com/oncology.html
Recent related publications:
Pharmacokinetics and pharmacodynamics of liposomal chemophototherapy with short drug-light intervals https://www.sciencedirect.com/science/article/pii/S0168365919300574
Blood Interactions, Pharmacokinetics, and Depth-Dependent Ablation of Rat Mammary Tumors with Photoactivatable, Liposomal Doxorubicin http://mct.aacrjournals.org/content/18/3/592
Chemophototherapy: An Emerging Treatment Option for Solid Tumors – Luo – 2018 – Advanced Science – Wiley Online Library https://onlinelibrary.wiley.com/doi/full/10.1002/advs.201600106%4010.1002/%28ISSN%292198-3844.Health-Medical-Life-Sciences#.XM5QTkwLXDs.reddit
Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release https://www.sciencedirect.com/science/article/pii/S0142961215008315
Source: Original link